CCI allows India Resurgence Fund to pick up equity in Digvijay Cement (See 'Corp Brief') CCI okays merger of ADES International Cayman, with and into Shelf Drilling (See 'Corp Brief') IBC - Assignment of loan by lender/bank to new entity does not necessarily require express consent of borrower, but knowledge by borrower would suffice: HC (See 'Legal Desk') Govt introduces new modalities under PMFBY to strengthen farmer protection (See 'Corp Brief') Second regional meeting of Urban Development Ministers held in Hyderabad (See 'Corp Brief') Trade Marks Act - New trade mark be struck off where it seeks to bank on existing goodwill accumulated by original trade mark & where original mark's owner has superior right over trade mark: HC (See 'Legal Desk') Reddy to inaugurate GSI's International Seminar in Jaipur (See 'Corp Brief') Joshi highlights role of technology in strengthening PDS and reaching the poorest (See 'Corp Brief') SAFEMA: If relative or associate of convict/detenue establish that property is not acquired with monies or assets provided by detenu, then properties of relatives/associates cannot be forfeited even if illegally acquired: SAFEMA (See 'Legal Desk') Mandaviya inaugurates EPFO's first-ever Modernised Digital Pavilion at IITF 2025 (See 'Corp Brief') NHAI takes Initiative to Publish Updates for Underbidding Projects on Website (See 'Corp Brief') India, Russia hold High-Level Interagency Consultations in New Delhi (See 'Corp Brief') Gati Shakti Vishwavidyalaya, DRDO sign MoU to develop Smart Tech Solutions (See 'Corp Brief') Misc - Legal heirs who are guilty of misconduct disentitles them to seek indulgence of Court to condone delay: HC (See 'Legal Desk') India unveils ARKA-GKT1, First Generation Energy-Efficient Edge Silicon Chip (See 'Corp Brief') MSME, KVIC, COIR and NSSH Pavilions inaugurated at Trade Fair (See 'Corp Brief') India highlights Rapid Telecom Transformation; Urges Collaborative Cybersecure Future (See 'Corp Brief') 5 institutes of Ministry of Earth Sciences brought under single umbrella (See 'Corp Brief') From Markets to Monuments: Advancing Clean Toilets and Hygienic Spaces (See 'Corp Brief') Capital Market - Fact that transactions in particular contract were reversed with same counterparty for same quantity of units, indicates prior meeting of minds with view to execute reversal trades at pre-determined price: SEBI (See 'Legal Desk') Puri visits Hanwha Ocean's shipbuilding facility in South Korea (See 'Corp Brief') IPR - Mere fact that any mark consists of numbers does not, in itself, make it unregistrable: HC (See 'Legal Desk') IndiaAI Zone unveiled showcasing India's Journey from Action to Impact (See 'Corp Brief') IPR - Counterfeiting not only harms brand reputation but also misleads consumers, making strict legal action necessary to deter such unlawful practices: HC (See 'Legal Desk') Puri holds Shipbuilding Meetings to boost India's Maritime Vision (See 'Corp Brief') Company Law - Company can prosecute any of its officers and when any officer of Company is to be prosecuted, then Section 439 of Companies Act would not be applicable: HC (See 'Legal Desk') AAI showcases future of Aviation at 44th India International Trade Fair 2025 (See 'Corp Brief') IPR - Mere identity or similarity of mark, of which registration is sought, and earlier mark, is not sufficient as ground to reject registration application: HC (See 'Legal Desk') India-Canada Ministerial Dialogue on Trade and Investment concludes (See 'Corp Brief') Misc - Remedy for recovery of money instituted under Article 226 of Constitution of India is not intended to enable claimant to recover monies, recovery of which by suit is barred by limitation: HC (See 'Legal Desk') Government intervention and Corporate governance (See CORP EINSICHT)

Print

Glenmark's Swiss arm gets nod to market Ryaltris nasal spray in Russia

Published: Feb 22, 2021

By TIOLCORPLAWS News Service

NEW DELHI, FEB 22, 2021: GLENMARK Pharmaceuticals on Monday said its Swiss subsidiary, Glenmark Specialty, has received marketing approval from Russian health regulators for its fixed-dose combination nasal spray, Ryaltris.

Ryaltris is indicated for symptomatic treatment of seasonal and perennial allergic rhinitis, like stuffy and runny nose, nasal itching, sneezing, as well as irritated eyes, in adults and children over 12 years of age.

"Glenmark has built strong capabilities in the area of respiratory medicine and is among the leading players in this therapy area across several markets globally. Russia is one of the key markets for us and we are consistently looking to expand our product portfolio," said Csaba Kantor, Senior Vice President - Russia and CIS region, Glenmark.

In Russia, allergic rhinitis affects 10-20 per cent of the population on average, with certain regions having a higher prevalence rate of 18-38 per cent.

"Glenmark has a strong established presence in Russia for over 30 years, which will enable us to lead the commercialization of this product in the country. We look forward to being able to make this innovative product available to patients in Russia as soon as possible," Mr Kantor added.

The company estimated that Ryaltris will be available to patients in Russia by the first quarter of 2021-22.

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
tioltube
TKF
TIOLawards
A TIOL Website. Copyright © 2025 TIOLcorplaws.com All rights reserved.